Sedric Secures $18.5 Million in Series A Funding to Fight Antimicrobial Resistance

We are thrilled to announce that Sedric, a global think tank committed to combating antimicrobial resistance, has successfully raised $18.5 million in funding from the Wellcome Trust. This significant investment is aimed at accelerating our mission of harnessing the power of data to address the pressing challenges posed by antimicrobial resistance. Sedric brings together a diverse coalition of experts across various disciplines to identify critical evidence gaps, devise actionable solutions, and advocate for impactful research and policy changes. With this new round of funding, we plan to expand our data initiatives, enhance our research capabilities, and further our outreach to policymakers and stakeholders worldwide. Our goal is to create data-driven insights that will inform strategies to effectively combat the rising threat of antimicrobial resistance. By pooling together knowledge, resources, and expertise, we aim to empower decision-makers with the tools and information necessary to implement sustainable interventions that protect public health. This funding is not just a financial boost but also a testament to the growing recognition of the urgent need for collaborative efforts in this field. At Sedric, we believe that through innovation, data transparency, and cross-sector partnerships, we can create a resilient global approach to one of the most critical health challenges of our time. Stay tuned for more updates as we embark on this transformative journey!